300 related articles for article (PubMed ID: 18443658)
1. Cancer proteomics by quantitative shotgun proteomics.
Chen EI; Yates JR
Mol Oncol; 2007 Sep; 1(2):144-59. PubMed ID: 18443658
[TBL] [Abstract][Full Text] [Related]
2. Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research.
Tian Q; Sangar V; Price ND
Mol Cell Proteomics; 2016 Feb; 15(2):362-7. PubMed ID: 26407994
[TBL] [Abstract][Full Text] [Related]
3. Trans-Proteomic Pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics.
Deutsch EW; Mendoza L; Shteynberg D; Slagel J; Sun Z; Moritz RL
Proteomics Clin Appl; 2015 Aug; 9(7-8):745-54. PubMed ID: 25631240
[TBL] [Abstract][Full Text] [Related]
4. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.
Boja ES; Rodriguez H
Korean J Lab Med; 2011 Apr; 31(2):61-71. PubMed ID: 21474978
[TBL] [Abstract][Full Text] [Related]
5. Rapid Multivariate Analysis Approach to Explore Differential Spatial Protein Profiles in Tissue.
Sharman K; Patterson NH; Weiss A; Neumann EK; Guiberson ER; Ryan DJ; Gutierrez DB; Spraggins JM; Van de Plas R; Skaar EP; Caprioli RM
J Proteome Res; 2023 May; 22(5):1394-1405. PubMed ID: 35849531
[TBL] [Abstract][Full Text] [Related]
6. Statistical Testing for Protein Equivalence Identifies Core Functional Modules Conserved across 360 Cancer Cell Lines and Presents a General Approach to Investigating Biological Systems.
Ergin EK; Myung JJK; Lange PF
J Proteome Res; 2024 Jun; 23(6):2169-2185. PubMed ID: 38804581
[TBL] [Abstract][Full Text] [Related]
7. DESP demixes cell-state profiles from dynamic bulk molecular measurements.
Youssef A; Paul I; Crovella M; Emili A
Cell Rep Methods; 2024 Mar; 4(3):100729. PubMed ID: 38490205
[TBL] [Abstract][Full Text] [Related]
8. Beyond the genome to tissue proteomics.
Liotta LA; Petricoin EF
Breast Cancer Res; 2000; 2(1):13-4. PubMed ID: 11250687
[No Abstract] [Full Text] [Related]
9. Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells.
Jafari A; Farahani M; Abdollahpour-Alitappeh M; Manzari-Tavakoli A; Yazdani M; Rezaei-Tavirani M
Front Oncol; 2023; 13():1277772. PubMed ID: 38328436
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases.
Wong GYM; Diakos C; Hugh TJ; Molloy MP
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682769
[TBL] [Abstract][Full Text] [Related]
11. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.
Vellan CJ; Jayapalan JJ; Yoong BK; Abdul-Aziz A; Mat-Junit S; Subramanian P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216204
[TBL] [Abstract][Full Text] [Related]
12. Rapid method towards proteomic analysis of dried blood spots by MALDI mass spectrometry.
Samenuk GM; Kelley AR; Perry G; Bach SBH
Clin Mass Spectrom; 2019 Apr; 12():30-36. PubMed ID: 34841077
[TBL] [Abstract][Full Text] [Related]
13. Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.
Eagle GL; Herbert JMJ; Zhuang J; Oates M; Khan UT; Kitteringham NR; Clarke K; Park BK; Pettitt AR; Jenkins RE; Falciani F
Sci Rep; 2021 Feb; 11(1):2932. PubMed ID: 33536534
[TBL] [Abstract][Full Text] [Related]
14. Refinements of LC-MS/MS Spectral Counting Statistics Improve Quantification of Low Abundance Proteins.
Lee HY; Kim EG; Jung HR; Jung JW; Kim HB; Cho JW; Kim KM; Yi EC
Sci Rep; 2019 Sep; 9(1):13653. PubMed ID: 31541118
[TBL] [Abstract][Full Text] [Related]
15. Novel predication of protein biomarkers in interferon-gamma-stimulated breast cancer cells.
Ssadh HA; Abdulmonem WA
Int J Health Sci (Qassim); 2019; 13(2):35-43. PubMed ID: 30983944
[TBL] [Abstract][Full Text] [Related]
16. The effects of nonignorable missing data on label-free mass spectrometry proteomics experiments.
O'Brien JJ; Gunawardena HP; Paulo JA; Chen X; Ibrahim JG; Gygi SP; Qaqish BF
Ann Appl Stat; 2018 Dec; 12(4):2075-2095. PubMed ID: 30473739
[TBL] [Abstract][Full Text] [Related]
17. Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation.
Soria J; Acera A; Merayo-LLoves J; Durán JA; González N; Rodriguez S; Bistolas N; Schumacher S; Bier FF; Peter H; Stöcklein W; Suárez T
Sci Rep; 2017 Dec; 7(1):17478. PubMed ID: 29234088
[TBL] [Abstract][Full Text] [Related]
18. A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.
Faria SS; Morris CF; Silva AR; Fonseca MP; Forget P; Castro MS; Fontes W
Front Oncol; 2017; 7():13. PubMed ID: 28265552
[TBL] [Abstract][Full Text] [Related]
19. QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.
Gunawardena HP; O'Brien J; Wrobel JA; Xie L; Davies SR; Li S; Ellis MJ; Qaqish BF; Chen X
Mol Cell Proteomics; 2016 Feb; 15(2):740-51. PubMed ID: 26598639
[TBL] [Abstract][Full Text] [Related]
20. Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis.
Uleberg KE; Ovestad IT; Munk AC; Brede C; van Diermen B; Gudlaugsson E; Janssen EA; Hjelle A; Baak JP
Int J Proteomics; 2014; 2014():129064. PubMed ID: 25018881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
